NPWT Reduction Mammaplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMedstar Health Research Institute
About this trial
In this prospective, randomized, split-body control trial, we aim to compare complications, patient-reported outcomes, and cost differentials following reduction mammaplasty with prophylactic closed incision negative pressure wound therapy versus standard adhesive dressing.
Eligibility criteria
Qualifiers
Female patients
Age 18 years or older
Scheduled to undergo bilateral reduction mammaplasty with a Wise pattern (anchor) incision and a superomedial, inferior, or central mound pedicle at MedStar Georgetown University Hospital or MedStar Good Samaritan Hospital
Able to comply with study procedures and follow-up visits
Disqualifiers
Younger than 18 years of age
Biologically male patients
Scheduled to undergo unilateral breast mammaplasty
Currently pregnant or lactating
Trial design
Treatments tested in this trial
- Prophylactic ciNPWT
- Standard Adhesive Dressing
Treatment groups
92 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medstar Health Research Institute
Lead sponsor
3M
Collaborator
Source ClinicalTrials.gov